14-15 November 2018
|European Case Law Identifier:||ECLI:EP:BA:2011:T143610.20110324|
|Date of decision:||24 March 2011|
|Case number:||T 1436/10|
|IPC class:||C07C 69/732|
|Language of proceedings:||EN|
|Download and more information:||
|Title of application:||CRYSTALS OF THE SODIUM SALT OF PRAVASTATIN|
|Applicant name:||LEK Pharmaceuticals d.d.|
|Opponent name:||STADA Arzneimittel AG
Harrison Goddard Foote
|Relevant legal provisions:||
|Keywords:||Missing statement of grounds|
Summary of Facts and Submissions
I. This is an appeal against the interlocutory decision of the Opposition Division of the European Patent Office posted 26 April 2010 concerning maintenance of the European Patent No. 1200385 in amended form.
A notice of appeal on behalf of the appellant patentee was filed on 5 July 2010. The appeal fee was paid on the same day. No separate statement of grounds of appeal was filed.
II. By a communication dated 1 October 2010 sent by registered letter with advice of delivery, the appellant patentee was informed that no statement of grounds of appeal had been filed and that, therefore, it was to be expected that the appeal would be rejected as inadmissible pursuant to Article 108, third sentence, EPC in conjunction with Rule 101(1) EPC. The appellant was invited to file observations within two months. A copy of the communication was sent to the respondents I and II (opponents 01 and 02, respectively) on the same day for information.
III. No answer has been given to the communication within the time limit.
Reasons for the Decision
As no written statement setting out the grounds of appeal has been filed and as the notice of appeal does not contain anything that could be regarded as a statement of grounds of appeal according to Article 108 EPC, the appeal has to be rejected as inadmissible (Article 108 EPC in conjunction with Rule 101(1) EPC).
For these reasons it is decided that:
The appeal is rejected as inadmissible.